Table 1.
Characteristics of the Study Population
| All Patients (N = 192) |
Recovered (N = 153) |
Deceased (N = 39) |
Healthy Controls† (N = 95) |
|
|---|---|---|---|---|
| Age, median (IQR), yr* | 58 (49–68) | 56 (46–65) | 67 (60–74) | 47 (33–61) |
| Sex, M, n (%) | 114 (59) | 87 (57) | 27 (69) | 38 (40) |
| Lopinavir–ritonavir treatment, n (%) | 95 (49) | 80 (52) | 15 (38) | N/A |
| Severity-A, n (%)* | ||||
| 3: no supplemental oxygen | 27 (14) | 22 (14) | 5 (13) | N/A |
| 4: supplemental oxygen | 137 (71) | 122 (80) | 15 (38) | N/A |
| 5: nasal high-flow oxygen/invasive mechanical ventilation | 28 (15) | 9 (6) | 19 (49) | N/A |
| Corticosteroid, n (%)* | 65 (34) | 39 (25) | 26 (67) | N/A |
| Comorbidity, n (%)* | 110 (57) | 80 (52) | 30 (77) | N/A |
| Duration of antibiotic use, median (IQR), d | 11 (7–14) | 11 (6–14) | 10 (7–15) | N/A |
| High-grade antibiotics, n (%)* | 43 (22) | 16 (10) | 27 (69) | N/A |
Definition of abbreviations: IQR = interquartile range; N/A = not available; Severity-A = severity on admission.
*
Characteristics that significantly differed between recovered patients and deceased patients.
†
Healthy controls were volunteers from the community in the same city. Only sex and age were collected.